Clinical Trials Browser

Phase 2 × Has results × sintilimab × Clear all

NCT05024968 2026-02-25

Sintilimab in Cancer of Unknown Primary

Phase 2 Completed

10 enrolled 9 charts

Neoplasms, Unknown Primary

NCT05017103 2024-12-11

Sintilimab for the Treatment of Locally Advanced, Metastatic, Recurrent, or Unresectable Undifferentiated Pleomorphic Sarcoma, SiARa Cancer Study

Phase 2 Terminated

6 enrolled 9 charts

Histiocytoma, Malignant Fibrous

NCT03116152 2021-02-03

Study of IBI308 With Advanced/Metastatic Esophageal Squamous Cell Carcinoma After Failure of First-line Treatment

Phase 2 Completed

190 enrolled 14 charts

Gastrointestinal

Esophageal Squamous Cell Carcinoma